The B-lymphoid Grb2 interaction code
Konstantin Neumann
Institute of Cellular and Molecular Immunology, Georg August University of Göttingen, Göttingen, Germany.
Search for more papers by this authorThomas Oellerich
Institute of Cellular and Molecular Immunology, Georg August University of Göttingen, Göttingen, Germany.
Search for more papers by this authorHenning Urlaub
Max Planck Institute of Biophysical Chemistry, Bioanalytical Mass Spectrometry Group, Göttingen, Germany.
Search for more papers by this authorJürgen Wienands
Institute of Cellular and Molecular Immunology, Georg August University of Göttingen, Göttingen, Germany.
Search for more papers by this authorKonstantin Neumann
Institute of Cellular and Molecular Immunology, Georg August University of Göttingen, Göttingen, Germany.
Search for more papers by this authorThomas Oellerich
Institute of Cellular and Molecular Immunology, Georg August University of Göttingen, Göttingen, Germany.
Search for more papers by this authorHenning Urlaub
Max Planck Institute of Biophysical Chemistry, Bioanalytical Mass Spectrometry Group, Göttingen, Germany.
Search for more papers by this authorJürgen Wienands
Institute of Cellular and Molecular Immunology, Georg August University of Göttingen, Göttingen, Germany.
Search for more papers by this authorAbstract
Summary: The growth factor receptor-bound protein 2 (Grb2) is a ubiquitously expressed and evolutionary conserved adapter protein possessing a plethora of described interaction partners for the regulation of signal transduction. In B lymphocytes, the Grb2-mediated scaffolding function controls the assembly and subcellular targeting of activating as well as inhibitory signalosomes in response to ligation of the antigen receptor. Also, integration of simultaneous signals from B-cell coreceptors that amplify or attenuate antigen receptor signal output relies on Grb2. Hence, Grb2 is an essential signal integrator. The key question remains, however, of how pathway specificity can be maintained during signal homeostasis critically required for the balance between immune cell activation and tolerance induction. Here, we summarize the molecular network of Grb2 in B cells and introduce a proteomic approach to elucidate the interactome of Grb2 in vivo.
References
- 1 Lowenstein EJ, et al. The Sh2 and Sh3 domain containing protein Grb2 links receptor tyrosine kinases to Ras signaling. Cell 1992; 70: 431–442.
- 2 Sadowski I, Stone JC, Pawson T. A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps. Mol Cell Biol 1986; 6: 4396–4408.
- 3 Matuoka K, Shibata M, Yamakawa A, Takenawa T. Cloning of ASH, a ubiquitous protein composed of one Src homology region (SH) 2 and two SH3 domains, from human and rat cDNA libraries. Proc Natl Acad Sci USA 1992; 89: 9015–9019.
- 4 Mayer BJ, Gupta R. Functions of SH2 and SH3 domains. Curr Top Microbiol Immunol 1998; 228: 1–22.
- 5 Songyang Z, et al. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol Cell Biol 1994; 14: 2777–2785.
- 6 Kessels HW, Ward AC, Schumacher TN. Specificity and affinity motifs for Grb2 SH2-ligand interactions. Proc Natl Acad Sci USA 2002; 99: 8524–8529.
- 7 Feng S, Chen JK, Yu H, Simon JA, Schreiber SL. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. Science 1994; 266: 1241–1247.
- 8 Sparks AB, Rider JE, Hoffman NG, Fowlkes DM, Quillam LA, Kay BK. Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2. Proc Natl Acad Sci USA 1996; 93: 1540–1544.
- 9 Lewitzky M, et al. The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif. Oncogene 2001; 20: 1052–1062.
- 10 Harkiolaki M, et al. Distinct binding modes of two epitopes in Gab2 that interact with the SH3C domain of Grb2. Structure 2009; 17: 809–822.
- 11 Maignan S, Guilloteau JP, Fromage N, Arnoux B, Becquart J, Ducruix A. Crystal structure of the mammalian Grb2 adaptor. Science 1995; 268: 291–293.
- 12 Yuzawa S, et al. Solution structure of Grb2 reveals extensive flexibility necessary for target recognition. J Mol Biol 2001; 306: 527–537.
- 13 Feng GS, Ouyang YB, Hu DP, Shi ZQ, Gentz R, Ni J. Grap is a novel SH3-SH2-SH3 adaptor protein that couples tyrosine kinases to the Ras pathway. J Biol Chem 1996; 271: 12129–12132.
- 14 Liu SK, McGlade CJ. Gads is a novel SH2 and SH3 domain-containing adaptor protein that binds to tyrosine-phosphorylated Shc. Oncogene 1998; 17: 3073–3082.
- 15 Law CL, et al. GrpL, a Grb2-related adaptor protein, interacts with SLP-76 to regulate nuclear factor of activated T cell activation. J Exp Med 1999; 189: 1243–1253.
- 16 Bourette RP, Arnaud S, Myles GM, Blanchet JP, Rohrschneider LR, Mouchiroud G. Mona, a novel hematopoietic-specific adaptor interacting with the macrophage colony-stimulating factor receptor, is implicated in monocyte/macrophage development. EMBO J 1998; 17: 7273–7281.
- 17 Ellis JH, Ashman C, Burden MN, Kilpatrick KE, Morse MA, Hamblin PA. GRID: a novel Grb-2-related adapter protein that interacts with the activated T cell costimulatory receptor CD28. J Immunol 2000; 164: 5805–5814.
- 18 Asada H, et al. Grf40, A novel Grb2 family member, is involved in T cell signaling through interaction with SLP-76 and LAT. J Exp Med 1999; 189: 1383–1390.
- 19 Qiu M, et al. Molecular cloning and expression of human grap-2, a novel leukocyte-specific SH2- and SH3-containing adaptor-like protein that binds to gab-1. Biochem Biophys Res Commun 1998; 253: 443–447.
- 20 Kayne PS, Sternberg PW. Ras pathways in Caenorhabditis elegans. Curr Opin Genet Dev 1995; 5: 38–43.
- 21 Simon MA. Signal transduction during the development of the Drosophila R7 photoreceptor. Dev Biol 1994; 166: 431–442.
- 22 Hafen E, Basler K, Edstroem JE, Rubin GM. Sevenless, a cell-specific homeotic gene of Drosophila, encodes a putative transmembrane receptor with a tyrosine kinase domain. Science 1987; 236: 55–63.
- 23 Olivier JP, et al. A Drosophila SH2-SH3 adaptor protein implicated in coupling the sevenless tyrosine kinase to an activator of Ras guanine nucleotide exchange, Sos. Cell 1993; 73: 179–191.
- 24 Simon MA, Dodson GS, Rubin GM. An SH3-SH2-SH3 protein is required for p21Ras1 activation and binds to sevenless and Sos proteins in vitro. Cell 1993; 73: 169–177.
- 25 Buday L, Downward J. Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor. Cell 1993; 73: 611–620.
- 26 Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AM, Weinberg RA. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 1993; 363: 45–51.
- 27 Gale NW, Kaplan S, Lowenstein EJ, Schlessinger J, Bar-Sagi D. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras. Nature 1993; 363: 88–92.
- 28 Li N, et al. Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature 1993; 363: 85–88.
- 29 Rozakis-Adcock M, Fernley R, Wade J, Pawson T, Bowtell D. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1. Nature 1993; 363: 83–85.
- 30 Skolnik EY, et al. The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling. EMBO J 1993; 12: 1929–1936.
- 31 Buday L, Downward J. Many faces of Ras activation. Biochim Biophys Acta 2008; 1786: 178–187.
- 32 Stern MJ, et al. The human GRB2 and Drosophila Drk genes can functionally replace the Caenorhabditis elegans cell signaling gene sem-5. Mol Biol Cell 1993; 4: 1175–1188.
- 33 Pelicci G, et al. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 1992; 70: 93–104.
- 34 Rozakis-Adcock M, et al. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 1992; 360: 689–692.
- 35 Reth M, Wienands J. Initiation and processing of signals from the B cell antigen receptor. Annu Rev Immunol 1997; 15: 453–479.
- 36 Kurosaki T, Hikida M. Tyrosine kinases and their substrates in B lymphocytes. Immunol Rev 2009; 228: 132–148.
- 37 Tordai A, Franklin RA, Patel H, Gardner AM, Johnson GL, Gelfand EW. Cross-linking of surface IgM stimulates the Ras/Raf-1/MEK/MAPK cascade in human B lymphocytes. J Biol Chem 1994; 269: 7538–7543.
- 38 Lankester AC, Van Schijndel GM, Rood PM, Verhoeven AJ, Van Lier RA. B cell antigen receptor cross-linking induces tyrosine phosphorylation and membrane translocation of a multimeric Shc complex that is augmented by CD19 co-ligation. Eur J Immunol 1994; 24: 2818–2825.
- 39 Saxton TM, Van Oostveen I, Bowtell D, Aebersold R, Gold MR. B cell antigen receptor cross-linking induces phosphorylation of the p21ras oncoprotein activators SHC and mSOS1 as well as assembly of complexes containing SHC, GRB-2, mSOS1, and a 145-kDa tyrosine-phosphorylated protein. J Immunol 1994; 153: 623–636.
- 40 Nagai K, Takata M, Yamamura H, Kurosaki T. Tyrosine phosphorylation of Shc is mediated through Lyn and Syk in B cell receptor signaling. J Biol Chem 1995; 270: 6824–6829.
- 41 Baumann G, Maier D, Freuler F, Tschopp C, Baudisch K, Wienands J. In vitro characterization of major ligands for Src homology 2 domains derived from protein tyrosine kinases, from the adaptor protein SHC and from GTPase-activating protein in Ramos B cells. Eur J Immunol 1994; 24: 1799–1807.
- 42 D’Ambrosio D, Hippen KL, Cambier JC. Distinct mechanisms mediate SHC association with the activated and resting B cell antigen receptor. Eur J Immunol 1996; 26: 1960–1965.
- 43 Smit L, De Vries-Smits AM, Bos JL, Borst J. B cell antigen receptor stimulation induces formation of a Shc-Grb2 complex containing multiple tyrosine-phosphorylated proteins. J Biol Chem 1994; 269: 20209–20212.
- 44 Smit L, Van Der Horst G, Borst J. Sos, Vav, and C3G participate in B cell receptor-induced signaling pathways and differentially associate with Shc-Grb2, Crk, and Crk-L adaptors. J Biol Chem 1996; 271: 8564–8569.
- 45 Harmer SL, DeFranco AL. Shc contains two Grb2 binding sites needed for efficient formation of complexes with SOS in B lymphocytes. Mol Cell Biol 1997; 17: 4087–4095.
- 46 Oh-hora M, Johmura S, Hashimoto A, Hikida M, Kurosaki T. Requirement for Ras guanine nucleotide releasing protein 3 in coupling phospholipase C-gamma2 to Ras in B cell receptor signaling. J Exp Med 2003; 198: 1841–1851.
- 47 Cherfils J, Chardin P. GEFs: structural basis for their activation of small GTP-binding proteins. Trends Biochem Sci 1999; 24: 306–311.
- 48 Wienands J, Schweikert J, Wollscheid B, Jumaa H, Nielsen PJ, Reth M. SLP-65: a new signaling component in B lymphocytes which requires expression of the antigen receptor for phosphorylation. J Exp Med 1998; 188: 791–795.
- 49 Fu C, Turck CW, Kurosaki T, Chan AC. BLNK: a central linker protein in B cell activation. Immunity 1998; 9: 93–103.
- 50 Engelke M, Engels N, Dittmann K, Stork B, Wienands J. Ca(2 + ) signaling in antigen receptor-activated B lymphocytes. Immunol Rev 2007; 218: 235–246.
- 51 Scharenberg AM, Humphries LA, Rawlings DJ. Calcium signalling and cell-fate choice in B cells. Nat Rev Immunol 2007; 7: 778–789.
- 52 Beaulieu N, et al. Regulation of RasGRP1 by B cell antigen receptor requires cooperativity between three domains controlling translocation to the plasma membrane. Mol Biol Cell 2007; 18: 3156–3168.
- 53 Tognon CE, Kirk HE, Passmore LA, Whitehead IP, Der CJ, Kay RJ. Regulation of RasGRP via a phorbol ester-responsive C1 domain. Mol Cell Biol 1998; 18: 6995–7008.
- 54 Aiba Y, et al. Activation of RasGRP3 by phosphorylation of Thr-133 is required for B cell receptor-mediated Ras activation. Proc Natl Acad Sci USA 2004; 101: 16612–16617.
- 55 Teixeira C, Stang SL, Zheng Y, Beswick NS, Stone JC. Integration of DAG signaling systems mediated by PKC-dependent phosphorylation of RasGRP3. Blood 2003; 102: 1414–1420.
- 56 Caloca MJ, Zugaza JL, Matallanas D, Crespo P, Bustelo XR. Vav mediates Ras stimulation by direct activation of the GDP/GTP exchange factor Ras GRP1. EMBO J 2003; 22: 3326–3336.
- 57 Coughlin JJ, Stang SL, Dower NA, Stone JC. RasGRP1 and RasGRP3 regulate B cell proliferation by facilitating B cell receptor-Ras signaling. J Immunol 2005; 175: 7179–7184.
- 58 Roose JP, Mollenauer M, Ho M, Kurosaki T, Weiss A. Unusual interplay of two types of Ras activators, RasGRP and SOS, establishes sensitive and robust Ras activation in lymphocytes. Mol Cell Biol 2007; 27: 2732–2745.
- 59 Damen JE, et al. The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase. Proc Natl Acad Sci USA 1996; 93: 1689–1693.
- 60 Lioubin MN, Algate PA, Tsai S, Carlberg K, Aebersold A, Rohrschneider LR. p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. Genes Dev 1996; 10: 1084–1095.
- 61 Crowley MT, Harmer SL, DeFranco AL. Activation-induced association of a 145-kDa tyrosine-phosphorylated protein with Shc and Syk in B lymphocytes and macrophages. J Biol Chem 1996; 271: 1145–1152.
- 62 Kavanaugh WM, et al. Multiple forms of an inositol polyphosphate 5-phosphatase form signaling complexes with Shc and Grb2. Curr Biol 1996; 6: 438–445.
- 63 Harmer SL, DeFranco AL. The src homology domain 2-containing inositol phosphatase SHIP forms a ternary complex with Shc and Grb2 in antigen receptor-stimulated B lymphocytes. J Biol Chem 1999; 274: 12183–12191.
- 64 Ingham RJ, et al. Tyrosine phosphorylation of shc in response to B cell antigen receptor engagement depends on the SHIP inositol phosphatase. J Immunol 1999; 163: 5891–5895.
- 65 Chacko GW, Tridandapani S, Damen JE, Liu L, Krystal G, Coggeshall KM. Negative signaling in B lymphocytes induces tyrosine phosphorylation of the 145-kDa inositol polyphosphate 5-phosphatase, SHIP. J Immunol 1996; 157: 2234–2238.
- 66 Gupta N, et al. Negative signaling pathways of the killer cell inhibitory receptor and Fc gamma RIIb1 require distinct phosphatases. J Exp Med 1997; 186: 473–478.
- 67 Muta T, Kurosaki T, Misulovin Z, Sanchez M, Nussenzweig MC, Ravetch JV. A 13-amino-acid motif in the cytoplasmic domain of Fc gamma RIIB modulates B-cell receptor signalling. Nature 1994; 368: 70–73.
- 68 Ono M, Bolland S, Tempst P, Ravetch JV. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB. Nature 1996; 383: 263–266.
- 69 Ono M, Okada H, Bolland S, Yanagi S, Kurosaki T, Ravetch JV. Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling. Cell 1997; 90: 293–301.
- 70 DiNitto JP, Lambright DG. Membrane and juxtamembrane targeting by PH and PTB domains. Biochim Biophys Acta 2006; 1761: 850–867.
- 71 Bolland S, Pearse RN, Kurosaki T, Ravetch JV. SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity 1998; 8: 509–516.
- 72 Scharenberg AM, et al. Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J 1998; 17: 1961–1972.
- 73 Brauweiler A, et al. Differential regulation of B cell development, activation, and death by the Src homology 2 domain-containing 5 ‘ inositol phosphatase (SHIP). J Exp Med 2000; 191: 1545–1554.
- 74 Hashimoto A, Hirose K, Okada H, Kurosaki T, Iino M. Inhibitory modulation of B cell receptor-mediated Ca2 + mobilization by Src homology 2 domain-containing inositol 5′-phosphatase (SHIP). J Biol Chem 1999; 274: 11203–11208.
- 75 Kiener PA, Lioubin MN, Rohrschneider LR, Ledbetter JA, Nadler SG, Diegel ML. Co-ligation of the antigen and Fc receptors gives rise to the selective modulation of intracellular signaling in B cells. Regulation of the association of phosphatidylinositol 3-kinase and inositol 5′-phosphatase with the antigen receptor complex. J Biol Chem 1997; 272: 3838–3844.
- 76 Liu Q, et al. The inositol polyphosphate 5-phosphatase ship is a crucial negative regulator of B cell antigen receptor signaling. J Exp Med 1998; 188: 1333–1342.
- 77 Okada H, et al. Role of the inositol phosphatase SHIP in B cell receptor-induced Ca2 + oscillatory response. J Immunol 1998; 161: 5129–5132.
- 78 Aman MJ, Lamkin TD, Okada H, Kurosaki T, Ravichandran KS. The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells. J Biol Chem 1998; 273: 33922–33928.
- 79 Gold MR, et al. Targets of B-cell antigen receptor signaling: the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase-3 signaling pathway and the Rap1 GTPase. Immunol Rev 2000; 176: 47–68.
- 80 Vigorito E, Turner M. Differential requirements of PI3K subunits for BCR or BCR/CD19-induced ERK activation. Adv Exp Med Biol 2006; 584: 43–52.
- 81 Bolland S, Ravetch JV. Inhibitory pathways triggered by ITIM-containing receptors. Adv Immunol 1999; 72: 149–177.
- 82 Isnardi I, Lesourne R, Bruhns P, Fridman WH, Cambier JC, Daeron M. Two distinct tyrosine-based motifs enable the inhibitory receptor FcgammaRIIB to cooperatively recruit the inositol phosphatases SHIP1/2 and the adapters Grb2/Grap. J Biol Chem 2004; 279: 51931–51938.
- 83 Rohrschneider LR, Fuller JF, Wolf I, Liu Y, Lucas DM. Structure, function, and biology of SHIP proteins. Genes Dev 2000; 14: 505–520.
- 84 Nitschke L, Tsubata T. Molecular interactions regulate BCR signal inhibition by CD22 and CD72. Trends Immunol 2004; 25: 543–550.
- 85 Nitschke L. The role of CD22 and other inhibitory co-receptors in B-cell activation. Curr Opin Immunol 2005; 17: 290–297.
- 86 Otipoby KL, Draves KE, Clark EA. CD22 regulates B cell receptor-mediated signals via two domains that independently recruit Grb2 and SHP-1. J Biol Chem 2001; 276: 44315–44322.
- 87 Yohannan J, Wienands J, Coggeshall KM, Justement LB. Analysis of tyrosine phosphorylation-dependent interactions between stimulatory effector proteins and the B cell co-receptor CD22. J Biol Chem 1999; 274: 18769–18776.
- 88
Fusaki N, et al.
BLNK is associated with the CD72/SHP-1/Grb2 complex in the WEHI231 cell line after membrane IgM cross-linking.
Eur J Immunol
2000; 30: 1326–1330.
10.1002/(SICI)1521-4141(200005)30:5<1326::AID-IMMU1326>3.0.CO;2-Q CAS PubMed Web of Science® Google Scholar
- 89 Wu Y, et al. The B-cell transmembrane protein CD72 binds to and is an in vivo substrate of the protein tyrosine phosphatase SHP-1. Curr Biol 1998; 8: 1009–1017.
- 90 Vogel W, Ullrich A. Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584. Cell Growth Differ 1996; 7: 1589–1597.
- 91 Wong L, Johnson GR. Epidermal growth factor induces coupling of protein-tyrosine phosphatase 1D to GRB2 via the COOH-terminal SH3 domain of GRB2. J Biol Chem 1996; 271: 20981–20984.
- 92 Stork B, et al. Grb2 and the non-T cell activation linker NTAL constitute a Ca(2 +)-regulating signal circuit in B lymphocytes. Immunity 2004; 21: 681–691.
- 93 Hashimoto A, et al. Involvement of guanosine triphosphatases and phospholipase C-gamma 2 in extracellular signal-regulated kinase, c-Jun NH2-terminal kinase, and p38 mitogen-activated protein kinase activation by the B cell antigen receptor. J Exp Med 1998; 188: 1287–1295.
- 94 Cong F, Yuan B, Goff SP. Characterization of a novel member of the DOK family that binds and modulates Abl signaling. Mol Cell Biol 1999; 19: 8314–8325.
- 95 Lemay S, Davidson D, Latour S, Veillette A. Dok-3, a novel adapter molecule involved in the negative regulation of immunoreceptor signaling. Mol Cell Biol 2000; 20: 2743–2754.
- 96 Stork B, et al. Subcellular localization of Grb2 by the adaptor protein Dok-3 restricts the intensity of Ca2 + signaling in B cells. EMBO J 2007; 26: 1140–1149.
- 97 Minoo P, Zadeh MM, Rottapel R, Lebrun J-J, Ali S. A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine receptor signaling. Blood 2004; 103: 1398–1407.
- 98 Hoek KL, et al. Transitional B cell fate is associated with developmental stage-specific regulation of diacylglycerol and calcium signaling upon B cell receptor engagement. J Immunol 2006; 177: 5405–5413.
- 99 Horejsi V, Zhang W, Schraven B. Transmembrane adaptor proteins: organizers of immunoreceptor signalling. Nat Rev Immunol 2004; 4: 603–616.
- 100 Wang Y, et al. Single and combined deletions of the NTAL/LAB and LAT adaptors minimally affect B-cell development and function. Mol Cell Biol 2005; 25: 4455–4465.
- 101 Engels N, et al. Recruitment of the cytoplasmic adaptor Grb2 to surface IgG and IgE provides antigen receptor-intrinsic costimulation to class-switched B cells. Nat Immunol 2009; 10: 1018–1025.
- 102 Horikawa K, et al. Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors. J Exp Med 2007; 204: 759–769.
- 103 Kaisho T, Schwenk F, Rajewsky K. The roles of gamma 1 heavy chain membrane expression and cytoplasmic tail in IgG1 responses. Science 1997; 276: 412–415.
- 104 Martin SW, Goodnow CC. Burst-enhancing role of the IgG membrane tail as a molecular determinant of memory. Nat Immunol 2002; 3: 182–188.
- 105 Waisman A, et al. IgG1 B cell receptor signaling is inhibited by CD22 and promotes the development of B cells whose survival is less dependent on Ig alpha/beta. J Exp Med 2007; 204: 747–758.
- 106 Grabbe A, Wienands J. Human SLP-65 isoforms contribute differently to activation and apoptosis of B lymphocytes. Blood 2006; 108: 3761–3768.
- 107 Tolar P, Sohn HW, Pierce SK. The initiation of antigen-induced B cell antigen receptor signaling viewed in living cells by fluorescence resonance energy transfer. Nat Immunol 2005; 6: 1168–1176.
- 108 Brooks SR, Kirkham PM, Freeberg L, Carter RH. Binding of cytoplasmic proteins to the CD19 intracellular domain is high affinity, competitive, and multimeric. J Immunol 2004; 172: 7556–7564.
- 109 Brooks SR, Li X, Volanakis EJ, Carter RH. Systematic analysis of the role of CD19 cytoplasmic tyrosines in enhancement of activation in Daudi human B cells: clustering of phospholipase C and Vav and of Grb2 and Sos with different CD19 tyrosines. J Immunol 2000; 164: 3123–3131.
- 110 Rickert RC. Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex. Curr Opin Immunol 2005; 17: 237–243.
- 111 Engel P, Zhou LJ, Ord DC, Sato S, Koller B, Tedder TF. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 1995; 3: 39–50.
- 112 Rickert RC, Rajewsky K, Roes J. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 1995; 376: 352–355.
- 113 Salzer U, Grimbacher B. Common variable immunodeficiency: the power of co-stimulation. Semin Immunol 2006; 18: 337–346.
- 114 Tedder TF, Poe JC, Fujimoto M, Haas KM, Sato S. The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system. Curr Dir Autoimmun 2005; 8: 55–90.
- 115 Fujikawa K, et al. Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells. J Exp Med 2003; 198: 1595–1608.
- 116 Depoil D, et al. CD19 is essential for B cell activation by promoting B cell receptor-antigen microcluster formation in response to membrane-bound ligand. Nat Immunol 2008; 9: 63–72.
- 117 Weber M, et al. Phospholipase C-gamma2 and Vav cooperate within signaling microclusters to propagate B cell spreading in response to membrane-bound antigen. J Exp Med 2008; 205: 853–868.
- 118 Arana E, et al. Activation of the small GTPase Rac2 via the B cell receptor regulates B cell adhesion and immunological-synapse formation. Immunity 2008; 28: 88–99.
- 119 Vigorito E, Kovesdi D, Turner M. Synergistic activation of PKD by the B cell antigen receptor and CD19 requires PI3K, Vav1 and PLCgamma. Cell Signal 2006; 18: 1455–1460.
- 120 Inabe K, Kurosaki T. Tyrosine phosphorylation of B-cell adaptor for phosphoinositide 3-kinase is required for Akt activation in response to CD19 engagement. Blood 2002; 99: 584–589.
- 121 Okada T, Maeda A, Iwamatsu A, Gotoh K, Kurosaki T. BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation. Immunity 2000; 13: 817–827.
- 122 Aiba Y, Kameyama M, Yamazaki T, Tedder TF, Kurosaki T. Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase. Blood 2008; 111: 1497–1503.
- 123 Nishida M, et al. Novel recognition mode between Vav and Grb2 SH3 domains. EMBO J 2001; 20: 2995–3007.
- 124 Ramos-Morales F, et al. The proline-rich region of Vav binds to Grb2 and Grb3-3. Oncogene 1995; 11: 1665–1669.
- 125 Ye ZS, Baltimore D. Binding of Vav to Grb2 through dimerization of Src homology 3 domains. Proc Natl Acad Sci USA 1994; 91: 12629–12633.
- 126 Johmura S, et al. Regulation of Vav localization in membrane rafts by adaptor molecules Grb2 and BLNK. Immunity 2003; 18: 777–787.
- 127 Ong SE, et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 2002; 1: 376–386.
- 128 Blagoev B, Kratchmarova I, Ong SE, Nielsen M, Foster LJ, Mann M. A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nat Biotechnol 2003; 21: 315–318.
- 129 Oellerich T, Gronborg M, Neumann K, Hsiao HH, Urlaub H, Wienands J. SLP-65 phosphorylation dynamics reveals a functional basis for signal integration by receptor-proximal adaptor proteins. Mol Cell Proteomics 2009; 8: 1738–1750.
- 130 Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 2008; 26: 1367–1372.
- 131 Cox J, et al. A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics. Nat Protoc 2009; 4: 698–705.
- 132 Den Hertog J, Tracy S, Hunter T. Phosphorylation of receptor protein-tyrosine phosphatase alpha on Tyr789, a binding site for the SH3-SH2-SH3 adaptor protein GRB-2 in vivo. EMBO J 1994; 13: 3020–3032.
- 133 Su J, Batzer A, Sap J. Receptor tyrosine phosphatase R-PTP-alpha is tyrosine-phosphorylated and associated with the adaptor protein Grb2. J Biol Chem 1994; 269: 18731–19834.
- 134 Veillette A, Rhee I, Souza CM, Davidson D. PEST family phosphatases in immunity, autoimmunity, and autoinflammatory disorders. Immunol Rev 2009; 228: 312–324.
- 135 Huang F, Gu H. Negative regulation of lymphocyte development and function by the Cbl family of proteins. Immunol Rev 2008; 224: 229–238.
- 136 Kitaura Y, et al. Control of the B cell-intrinsic tolerance programs by ubiquitin ligases Cbl and Cbl-b. Immunity 2007; 26: 567–578.
- 137 Ota S, et al. The RING finger domain of Cbl is essential for negative regulation of the Syk tyrosine kinase. J Biol Chem 2000; 275: 414–422.
- 138 Rao N, et al. The non-receptor tyrosine kinase Syk is a target of Cbl-mediated ubiquitylation upon B-cell receptor stimulation. EMBO J 2001; 20: 7085–7095.
- 139 Sohn HW, Gu H, Pierce SK. Cbl-b negatively regulates B cell antigen receptor signaling in mature B cells through ubiquitination of the tyrosine kinase Syk. J Exp Med 2003; 197: 1511–1524.
- 140 Dragone LL, et al. Src-like adaptor protein (SLAP) regulates B cell receptor levels in a c-Cbl-dependent manner. Proc Natl Acad Sci USA 2006; 103: 18202–18207.
- 141 Panchamoorthy G, et al. p120cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in vivo with Fyn and Syk tyrosine kinases, Grb2 and Shc adaptors, and the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem 1996; 271: 3187–3194.
- 142 Yankee TM, Solow SA, Draves KD, Clark EA. Expression of the Grb2-related protein of the lymphoid system in B cell subsets enhances B cell antigen receptor signaling through mitogen-activated protein kinase pathways. J Immunol 2003; 170: 349–355.
- 143 Donovan JA, Wange RL, Langdon WY, Samelson LE. The protein product of the c-cbl protooncogene is the 120-kDa tyrosine-phosphorylated protein in Jurkat cells activated via the T cell antigen receptor. J Biol Chem 1994; 269: 22921–22924.
- 144 Meisner H, Conway BR, Hartley D, Czech MP. Interactions of Cbl with Grb2 and phosphatidylinositol 3′-kinase in activated Jurkat cells. Mol Cell Biol 1995; 15: 3571–3578.
- 145 Keshava Prasad TS, et al. Human Protein Reference Database--2009 update. Nucleic Acids Res 2009; 37: D767–D772.
- 146 Hermjakob H, et al. IntAct: an open source molecular interaction database. Nucleic Acids Res 2004; 32: D452–D455.
- 147 Cheng AM, et al. Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. Cell 1998; 95: 793–803.
- 148 Ware MD, Rosten P, Damen JE, Liu L, Humphries RK, Krystal G. Cloning and characterization of human SHIP, the 145-kD inositol 5-phosphatase that associates with SHC after cytokine stimulation. Blood 1996; 88: 2833–2840.
- 149 Honma M, et al. Dok-3 sequesters Grb2 and inhibits the Ras-Erk pathway downstream of protein-tyrosine kinases. Genes Cells 2006; 11: 143–151.
- 150 Chardin P, et al. Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. Science 1993; 260: 1338–1343.
- 151 Houtman JC, et al. Oligomerization of signaling complexes by the multipoint binding of GRB2 to both LAT and SOS1. Nat Struct Mol Biol 2006; 13: 798–805.
- 152 Yoon SY, Koh WS, Lee MK, Park YM, Han MY. Dynamin II associates with Grb2 SH3 domain in Ras transformed NIH3T3 cells. Biochem Biophys Res Commun 1997; 234: 539–543.
- 153 Anafi M, Kiefer F, Gish GD, Mbamalu G, Iscove NN, Pawson T. SH2/SH3 adaptor proteins can link tyrosine kinases to a Ste20-related protein kinase, HPK1. J Biol Chem 1997; 272: 27804–27811.
- 154 Oehrl W, et al. The germinal center kinase (GCK)-related protein kinases HPK1 and KHS are candidates for highly selective signal transducers of Crk family adapter proteins. Oncogene 1998; 17: 1893–1901.
- 155 Liou J, et al. HPK1 is activated by lymphocyte antigen receptors and negatively regulates AP-1. Immunity 2000; 12: 399–408.
- 156 Smit L, Van Der Horst G, Borst J. Formation of Shc/Grb2- and Crk adaptor complexes containing tyrosine phosphorylated Cbl upon stimulation of the B-cell antigen receptor. Oncogene 1996; 13: 381–389.
- 157 Wu C, et al. Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening. Proteomics 2007; 7: 1775–1785.
- 158 Scholler JK, Perez-Villar JJ, O’Day K, Kanner SB. Engagement of the T lymphocyte antigen receptor regulates association of son-of-sevenless homologues with the SH3 domain of phospholipase Cgamma1. Eur J Immunol 2000; 30: 2378–2387.
- 159 Yang SS, Van Aelst L, Bar-Sagi D. Differential interactions of human Sos1 and Sos2 with Grb2. J Biol Chem 1995; 270: 18212–18215.
- 160 Elly C, et al. Tyrosine phosphorylation and complex formation of Cbl-b upon T cell receptor stimulation. Oncogene 1999; 18: 1147–1156.
- 161 Ettenberg SA, et al. cbl-b inhibits epidermal growth factor receptor signaling. Oncogene 1999; 18: 1855–1866.
- 162 Den Hertog J, Hunter T. Tight association of GRB2 with receptor protein-tyrosine phosphatase alpha is mediated by the SH2 and C-terminal SH3 domains. EMBO J 1996; 15: 3016–3027.
- 163 Charest A, Wagner J, Kwan M, Tremblay ML. Coupling of the murine protein tyrosine phosphatase PEST to the epidermal growth factor (EGF) receptor through a Src homology 3 (SH3) domain-mediated association with Grb2. Oncogene 1997; 14: 1643–1651.
- 164 Wheeler M, Domin J. Recruitment of the class II phosphoinositide 3-kinase C2beta to the epidermal growth factor receptor: role of Grb2. Mol Cell Biol 2001; 21: 6660–6667.
- 165 Wang J, Auger KR, Jarvis L, Shi Y, Roberts TM. Direct association of Grb2 with the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem 1995; 270: 12774–12780.
- 166 Itoh S, et al. Adapter molecule Grb2-associated binder 1 is specifically expressed in marginal zone B cells and negatively regulates thymus-independent antigen-2 responses. J Immunol 2002; 168: 5110–5116.
- 167 Holgado-Madruga M, Emlet DR, Moscatello DK, Godwin AK, Wong AJ. A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature 1996; 379: 560–564.
- 168 Ramos-Morales F, Druker BJ, Fischer S. Vav binds to several SH2/SH3 containing proteins in activated lymphocytes. Oncogene 1994; 9: 1917–1923.
- 169 Saci A, Liu WQ, Vidal M, Garbay C, Rendu F, Bachelot-Loza C. Differential effect of the inhibition of Grb2-SH3 interactions in platelet activation induced by thrombin and by Fc receptor engagement. Biochem J 2002; 363: 717–725.
- 170 Momose H, et al. Dual phosphorylation of phosphoinositide 3-kinase adaptor Grb2-associated binder 2 is responsible for superoxide formation synergistically stimulated by Fc gamma and formyl-methionyl-leucyl-phenylalanine receptors in differentiated THP-1 cells. J Immunol 2003; 171: 4227–4234.
- 171 Koonpaew S, Janssen E, Zhu M, Zhang W. The importance of three membrane-distal tyrosines in the adaptor protein NTAL/LAB. J Biol Chem 2004; 279: 11229–11235.
- 172 Zhu M, Janssen E, Leung K, Zhang W. Molecular cloning of a novel gene encoding a membrane-associated adaptor protein (LAX) in lymphocyte signaling. J Biol Chem 2002; 277: 46151–46158.
- 173 Liu Y, Zhang W. Identification of a new transmembrane adaptor protein that constitutively binds Grb2 in B cells. J Leukoc Biol 2008; 84: 842–851.
- 174 Takemoto Y, Furuta M, Sato M, Findell PR, Ramble W, Hashimoto Y. Growth factor receptor-bound protein 2 (Grb2) association with hemopoietic specific protein 1: linkage between Lck and Grb2. J Immunol 1998; 161: 625–630.